InNexus Biotechnology, Inc.
IXSBF
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Net Income | 28.60% | 15.72% | 49.60% | -18.76% | -10.29% |
| Total Depreciation and Amortization | 28.73% | -3.23% | -9.64% | -2.75% | -14.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.58% | -18.74% | -47.94% | 94.57% | -8.50% |
| Change in Net Operating Assets | -37.89% | 50.93% | -78.80% | -29.37% | 338.01% |
| Cash from Operations | -82.60% | 54.27% | 5.81% | 39.70% | 50.42% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 186.84% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -2,021.05% | -- |
| Total Debt Issued | -46.36% | -8.75% | 6,548.00% | -100.98% | -27.72% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -67.01% | -6.38% | -28.29% | -11.89% | -45.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -184.28% | 421.79% | 425.00% | -229.73% | 108.60% |